Today, the EUCAIM Consortium gathered in Brussels and online for its third consortium meeting, bringing together partners to discuss the project’s progress and next steps.
We are delighted to announce that GE Medical Systems has officially joined the EUCAIM consortium as of January 2025! This marks an exciting milestone for
The European Society of Radiology (ESR) and the European Federation for Cancer Images (EUCAIM) consortium are thrilled to announce the release of the Joint Statement
We are thrilled to announce that the pre-notification of the European Digital Infrastructure Consortium (EDIC) application for EUCAIM has been successfully submitted to the European
EUCAIM is excited to announce its participation in the European Congress of Radiology (ECR) 2025! The project will be highlighted in two sessions, showcasing our
We are excited to announce a collaborative event organised by the European Commission, the European Society of Radiology (ESR), and the EUCAIM project. This event
We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.
Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.
Apply by 10 June 2024!
We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.
EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.
Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.
Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.